文章摘要
樊静,丛舒,王宁,吕学莉,包鹤龄,王宝华,冯雅靖,杨汀,王临虹,方利文.2014-2015年中国40岁及以上慢性阻塞性肺疾病患者肺炎疫苗接种状况[J].中华流行病学杂志,2020,41(7):1028-1033
2014-2015年中国40岁及以上慢性阻塞性肺疾病患者肺炎疫苗接种状况
Pneumococcal vaccination rate in chronic obstructive pulmonary disease patients aged 40 years or older in China, 2014-2015
收稿日期:2020-01-24  出版日期:2020-07-15
DOI:10.3760/cma.j.cn112338-20200124-00056
中文关键词: 慢性阻塞性肺疾病;肺炎疫苗接种;预防
英文关键词: Chronic obstructive pulmonary disease;Pneumococcal vaccination;Prevention
基金项目:国家重点研发计划(2016YFC1303905,2016YFC1303900);中央转移支付重大公共卫生项目
作者单位E-mail
樊静 中国疾病预防控制中心慢性非传染性疾病预防控制中心, 北京 100050  
丛舒 中国疾病预防控制中心慢性非传染性疾病预防控制中心, 北京 100050  
王宁 中国疾病预防控制中心慢性非传染性疾病预防控制中心, 北京 100050  
吕学莉 中国疾病预防控制中心慢性非传染性疾病预防控制中心, 北京 100050  
包鹤龄 中国疾病预防控制中心慢性非传染性疾病预防控制中心, 北京 100050  
王宝华 中国疾病预防控制中心慢性非传染性疾病预防控制中心, 北京 100050  
冯雅靖 中国疾病预防控制中心慢性非传染性疾病预防控制中心, 北京 100050  
杨汀 中日友好医院呼吸医学中心, 北京 100029  
王临虹 中国疾病预防控制中心慢性非传染性疾病预防控制中心, 北京 100050  
方利文 中国疾病预防控制中心慢性非传染性疾病预防控制中心, 北京 100050 fangliwen@ncncd.chinacdc.cn 
摘要点击次数: 582
全文下载次数: 235
中文摘要:
      目的 了解我国≥40岁慢性阻塞性肺疾病(慢阻肺)患者的肺炎疫苗接种状况,为慢阻肺的防控提供科学依据。方法 将2014-2015年中国居民慢性阻塞性肺疾病监测中支气管舒张试验后测试FEV1/FVC<70%的调查对象作为慢阻肺患者,其中9 067名通过询问调查明确肺炎疫苗接种情况的患者被纳入本研究分析。应用复杂抽样调整方法,估计慢阻肺患者中的肺炎疫苗接种率及其95% CI,并对其影响因素进行分析。结果 我国≥40岁慢阻肺患者的5年内肺炎疫苗接种率是0.8%(95% CI:0.3%~1.4%)。40~岁组患者的肺炎疫苗接种率是0.3%(95% CI:0.2%~0.5%),≥60岁组患者的接种率为1.2%(95% CI:0.3%~2.1%)(P<0.05);城镇患者的接种率(1.5%)高于乡村患者(0.4%)(P<0.05);慢阻肺患者的气流受限程度越严重,其肺炎疫苗接种率越高(P<0.05);合并其他慢性肺部疾病或糖尿病的患者接种率为1.7%、2.1%,高于未合并的患者(P<0.05);曾经吸烟的慢阻肺患者肺炎疫苗接种率为1.4%,现在吸烟的患者接种率为0.6%。慢阻肺患者的肺炎疫苗接种与年龄、文化程度、职业、气流受限严重程度分级、流感疫苗接种史有关。结论 我国≥40岁慢阻肺患者的肺炎疫苗接种率非常低,需要采取多种措施加强对慢阻肺患者的健康教育与肺炎疫苗接种推荐。
英文摘要:
      Objective To understand the pneumococcal vaccination rate in chronic obstructive pulmonary disease (COPD) patients aged 40 years or older in China and provide evidence for COPD control and prevention. Methods COPD patients with post-bronchodilator FEV1/FVC<70% in COPD surveillance (2014-2015) of China were used as study subjects, in which 9 067 patients with definite pneumococcal vaccination status were included. The pneumococcal vaccination rate and its 95%CI in COPD patients were estimated using data adjusted by complicated sampling method. The factors in association with the vaccination rate were also identified. Results The pneumococcal vaccination rate was 0.8% in the past five years in COPD patients aged 40 years or older in China (95%CI:0.3%-1.4%). The vaccination rate was 0.3% in the patients aged 40 to 59 years (95%CI:0.2%-0.5%) and 1.2% in the patients aged 60 years or older (95%CI:0.3%-2.1%) (P<0.05). The rate was higher in the patients living in urban area (1.5%) than in those living in rural area (0.4%) (P<0.05). The vaccination rate increased with the severity of airflow limitation (P<0.05). The patients with comorbidities of other chronic lung diseases or diabetes had higher vaccination rate (1.7% and 2.1%) compared with those without comorbidities (P<0.05). The vaccination rate was 1.4% in former smokers and 0.6% in current smokers. The pneumococcal vaccination rate in COPD patients was associated with age, education level, occupation, the severity of airflow limitation and the history of influenza vaccination. Conclusions The pneumococcal vaccination rate was extremely low in COPD patients aged 40 years or older in China. It is necessary to strengthen the health education and recommendation for pneumococcal vaccination in COPD patients through different measures.
查看全文   Html全文     查看/发表评论  下载PDF阅读器
关闭